Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Original Articles

Machine learning-based 2-year risk prediction tool in immunoglobulin A nephropathy: Yujeong Kim, Jong Hyun Jhee, Chan Min Park et al.; Received March 22, 2023 Accepted July 17, 2023 Published online October 27, 2023; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial: Keiji Hirai, Susumu Ookawara, Taisuke Kitano et al.; Kidney Res Clin Pract. 2017;36(2):159-166. Published online June 30, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.2.159
Web of Science 4 Cited By 3; Full text PubReader PDF

Plasma endocan level and prognosis of immunoglobulin A nephropathy: Yu Ho Lee, Jin Sug Kim, Se-Yun Kim et al.; Kidney Res Clin Pract. 2016;35(3):152-159. Published online July 14, 2016; DOI: https://doi.org/10.1016/j.krcp.2016.07.001
Web of Science 19 Cited By 18; Full text PubReader PDF

Clinical manifestations of IgA nephropathy combined with thin glomerular basement membrane nephropathy in children: Young Ju Hwang, Dong Sub Kim, Cheol Woo Ko, Min Hyun Cho, Tae In Park; Kidney Res Clin Pract. 2013;32(3):111-114. Published online September 4, 2013; DOI: https://doi.org/10.1016/j.krcp.2013.07.001
Cited By 3; Full text PubReader PDF

Hyperuricemia as a marker for progression of immunoglobulin A nephropathy: Su-Ji Kim, Jung-Hoon Kim, Hyo-Wook Gil, Jong-Oh Yang, Eun-Young Lee, Sae-Yong Hong; Kidney Res Clin Pract. 2012;31(3):186-191. Published online July 20, 2012; DOI: https://doi.org/10.1016/j.krcp.2012.07.003
Cited By 4; Full text PubReader PDF

15-Deoxy-Delta(12,14)-Prostaglandin J2 and Proinflammatory Cytokines in IgA Nephropathy: You Seok Jeong, M.D., Sang Heon Song, M.D., Dong Won Lee, M.D., Soo Bong Lee, M.D., Byeong Yun Yang, M.D. and Ihm Soo Kwak, M.D.; Korean J Nephrol. 2008;27(3):307-318.; PDF

Volume 43, No. 2

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.0

MOST VIEWED MOST CITED

15,122	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
20,033	C4d Puzzle in ABO-incompatible kidney transplantation
8,637	How should we treat acute kidney injury caused by renal congestion?
35,510	Uremic pruritus: pathophysiology, clinical presentation, and treatments
13,278	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options

Cited By 15	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2024 by The Korean Society of Nephrology.